Featured Research

from universities, journals, and other organizations

Old habits die hard: Helping cancer patients stop smoking

Date:
November 26, 2012
Source:
University of Michigan
Summary:
It's a sad but familiar scene near the grounds of many medical campuses: hospital-gowned patients, some toting rolling IV poles, huddled in clumps under bus shelters or warming areas, smoking cigarettes.

It's a sad but familiar scene near the grounds of many medical campuses: hospital-gowned patients, some toting rolling IV poles, huddled in clumps under bus shelters or warming areas, smoking cigarettes.

Smoking causes 30 percent of all cancer deaths and 87 percent of all lung cancer deaths. Yet, roughly 50 percent to 83 percent of cancer patients keep smoking after a cancer diagnosis, through treatment and beyond, says Sonia Duffy, University of Michigan School of Nursing researcher. For patients who quit on their own, relapse rates (as in the general population) are as high as 85 percent.

Yet, continued smoking severely hampers cancer treatment, increases cancer recurrence and decreases survival, she says.

While it's easy to dismiss smoking as a lack of discipline or a disregard for one's own health, it's a much more complicated picture for these patients, says Duffy, lead researcher on the review paper, "Why Do Cancer Patients Smoke and What Can Providers Do About It," which appears in the journal Community Oncology.

"Ours is the first comprehensive review study to examine reasons why the very cause of the cancer, namely smoking, in many cases isn't treated," said Duffy, who said she wasn't prepared to find so many hurdles hindering smoking cessation in cancer patients.

"I think what surprised me when I did the review was the multitude of issues that cancer patients face, and that there are so many variables affecting why they don't get treatment, and if they do get treatment, why they may not respond. Nicotine addiction, health issues, emotional issues, psychological issues and system level issues are all in the way."

Other obstacles include limited access to quit-smoking programs, little social support, sleep deprivation, poor nutrition, lack of confidence in being able to quit and socioeconomic status. After back-to-back appointments and grueling chemotherapy or radiation protocols, many cancer patients simply lack time or energy to attend quit-smoking programs, Duffy says.

Depression is another big barrier to quitting smoking, and among cancer patients it's as high as 58 percent, compared to 10 percent in the general population, she says. And, while most lung cancer patients understand the relationship between smoking and their diagnosis, head-and-neck-cancer patients often don't make the connection.

Surprisingly, Duffy's research suggests that only 56 percent of family physicians urge their cancer patients to quit smoking. Most oncology providers suggest quitting, but the oncologist's main focus is on cancer treatment. Duffy's paper suggests that nurse-administered stop-smoking interventions may be the best way to reach cancer patients who smoke, yet many nurses are not trained to conduct cessation interventions. Duffy's next project will examine ways to specifically design quit-smoking programs for nurses to administer to cancer patients.

Duffy also has appointments at the Ann Arbor VA Center for Clinical Management Research and the U-M departments of Otolaryngology and Psychiatry. Other authors include Samantha Louzon of the Ann Arbor VA Center for Clinical Management Research and Ellen Gritz of the University of Texas MD Anderson Cancer Center.


Story Source:

The above story is based on materials provided by University of Michigan. Note: Materials may be edited for content and length.


Journal Reference:

  1. Sonia A. Duffy, Samantha A. Louzon, Ellen R. Gritz. Why do cancer patients smoke and what can providers do about it? Community Oncology, 2012; 9 (11): 344 DOI: 10.1016/j.cmonc.2012.10.003

Cite This Page:

University of Michigan. "Old habits die hard: Helping cancer patients stop smoking." ScienceDaily. ScienceDaily, 26 November 2012. <www.sciencedaily.com/releases/2012/11/121126110429.htm>.
University of Michigan. (2012, November 26). Old habits die hard: Helping cancer patients stop smoking. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2012/11/121126110429.htm
University of Michigan. "Old habits die hard: Helping cancer patients stop smoking." ScienceDaily. www.sciencedaily.com/releases/2012/11/121126110429.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins